GluSense is developing a miniature injectable continuous glucose sensor. The sensor will be injected under the skin and will transmit continuous glucose values to an external wearable device for up to a full year, significantly improving the quality of life of diabetes patients.

Our product

Glyde CGM includes a miniature implant, injected under the skin, and an external wearable device that reads glucose data from the implant.

Our technology

GlydeTM CGM is a miniature, long term, implantable continuous glucose monitoring system for both Type 1 and insulin-dependent Type2 diabetes patients.

Our team

GluSense is developing an innovative long-term, injectable continuous glucose sensor for diabetes patients.